BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2354 related articles for article (PubMed ID: 28620797)

  • 1. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
    Omata M; Cheng AL; Kokudo N; Kudo M; Lee JM; Jia J; Tateishi R; Han KH; Chawla YK; Shiina S; Jafri W; Payawal DA; Ohki T; Ogasawara S; Chen PJ; Lesmana CRA; Lesmana LA; Gani RA; Obi S; Dokmeci AK; Sarin SK
    Hepatol Int; 2017 Jul; 11(4):317-370. PubMed ID: 28620797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Global epidemiology of hepatocellular carcinoma].
    Kiyosawa K; Sodeyama T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():13-9. PubMed ID: 11761928
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular carcinoma: an Asian perspective.
    Teo EK; Fock KM
    Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.
    Fong ZV; Tanabe KK
    Cancer; 2014 Sep; 120(18):2824-38. PubMed ID: 24897995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
    Seeff LB; Hoofnagle JH
    Oncogene; 2006 Jun; 25(27):3771-7. PubMed ID: 16799618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation.
    Song P; Tang W; Tamura S; Hasegawa K; Sugawara Y; Dong J; Kokudo N
    Biosci Trends; 2010 Dec; 4(6):283-7. PubMed ID: 21248425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.
    Kim YA; Trinh S; Thura S; Kyi KP; Lee T; Sze S; Richards A; Aronsohn A; Wong GLH; Tanaka Y; Dusheiko G; Nguyen MH
    PLoS One; 2017; 12(8):e0181603. PubMed ID: 28797080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.
    Lee JM; Park JW; Choi BI
    Dig Dis; 2014; 32(6):764-77. PubMed ID: 25376295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.
    Davídsdóttir L; Duberg AS; Törner A; Aleman S; Bäck E; Ekdahl K; Blaxhult A; Ekbom A; Hultcrantz R
    Scand J Gastroenterol; 2010 Aug; 45(7-8):944-52. PubMed ID: 20384529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
    Nguyen VT; Razali K; Amin J; Law MG; Dore GJ
    J Gastroenterol Hepatol; 2008 Jun; 23(6):922-9. PubMed ID: 17608637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis and cancer: genetic aspects.
    Olsson R
    Scand J Gastroenterol Suppl; 1996; 220():115-20. PubMed ID: 8898447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?
    Chow PK
    J Gastroenterol Hepatol; 2012 Mar; 27(3):452-7. PubMed ID: 22142283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis virus and hepatocellular carcinoma].
    Rosmorduc O; Paterlini P; Poupon R; Brechot C
    Gastroenterol Clin Biol; 1999 Mar; 23(3):363-75. PubMed ID: 10384341
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.
    Zhu RX; Seto WK; Lai CL; Yuen MF
    Gut Liver; 2016 May; 10(3):332-9. PubMed ID: 27114433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of hepatocellular carcinoma and its viral risk factors.
    Kew MC
    Acta Gastroenterol Belg; 2000; 63(2):227-9. PubMed ID: 10925474
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
    Masuzaki R; Yoshida H; Tateishi R; Shiina S; Omata M
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1137-51. PubMed ID: 19187872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon.
    Kim SK; Kim SR; Imoto S; Tohyama M; Otono Y; Tamura T; Kim KI; Kobayashi M; Ohtani A; Sugimoto K; Mizuguchi A; Hiramatsu Y; Kudo M
    Oncology; 2015; 89 Suppl 2():60-9. PubMed ID: 26584037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 118.